December 10‚ 2006
ANTHERA EMPLOYEE KEIKO MITSUNOBU FINISHES HONOLULU MARATHON IN SUCCESSFUL EFFORT TO RAISE MONEY FOR CHILDREN’S HOSPITAL OAKLAND RESEARCH INSTITUTE
San Mateo‚ CA – December 10‚ 2006 – After months of hard training, combined with an extraordinary personal effort to raise money for Children’s Hospital Oakland Research Institute (CHORI), Keiko Mitsunobu, Senior Director of Business Development at Anthera Pharmaceuticals, finished the Honolulu marathon in just over four hours. Nearly 70,000 people showed for the 34th Annual Honolulu Marathon. Thanks to the generosity of Anthera’s investors, directors, employees, and key consultants, $5,200 will be donated to CHORI to support research efforts in areas such as sickle cell and other childhood diseases. “We are all proud of what Keiko has accomplished for both Children’s Hospital Oakland and herself”, stated Paul F. Truex, President and CEO of Anthera Pharmaceuticals. “We hope Keiko’s efforts will serve as a benchmark for other companies and individuals to support research in under-funded areas such as this.”
About Children’s Hospital Oakland Research Institute (CHORI)
An internationally renowned biomedical research institute, CHORI bridges basic science and clinical research in the treatment and prevention of human disease. CHORI is a leader in translational research, providing cures for blood diseases, developing new vaccines for infectious diseases, and discovering new treatment protocols for previously fatal or debilitating conditions. Striving to provide the highest standard of excellence and innovation, CHORI brings together a multidisciplinary collaborative of distinguished investigators in six different Centers of Research: The Center for Cancer Research, The Center for Genetics, The Center for Immunobiology & Vaccine Development, The Center for Nutrition & Metabolism, The Center for Prevention of Obesity, Cardiovascular Disease & Diabetes, and The Center for Sickle Cell Disease & Thalassemia. Within these major areas of focus, CHORI pushes the frontiers of science – and of excellence – beyond their borders. Among the leading biotech enterprises in the Bay Area, CHORI produced 25 patents in the last 5 years alone. In addition to providing world-class research, CHORI is also a teaching institute, offering unique educational opportunities to high school, college, doctoral and post-doctoral students. A collaborative nexus for innovative research and learning that stretches beyond local boundaries, CHORI is at the forefront of basic and clinical research that strives to change the world - one patient at a time. For more information about CHORI please visit www.chori.org.
About Anthera Pharmaceuticals
Anthera Pharmaceuticals is a pharmaceutical development company focused on the development and advancement of promising clinical
products for the treatment of serious inflammatory diseases. The Company has acquired worldwide rights (ex. Japan) to a series of
clinical and pre–clinical products that inhibit the enzymatic activity of secretory phospholipase 
– a group of enzymes
responsible for the release of arachidonic acid and subsequent production of leukotrienes‚ prostacyclins and other mediators
of inflammation. These highly potent compounds inhibit novel– upstream steps in the inflammation cascade and have the potential
to address a variety of diseases. For more information please visit: www.anthera.com.
CONTACT:
Press Relations
510-277-1208
PR@anthera.com
###